首页> 外文期刊>South African medical journal = >Publication trends of clinical trials performed in South Africa
【24h】

Publication trends of clinical trials performed in South Africa

机译:南非进行的临床试验的出版趋势

获取原文
       

摘要

BACKGROUND. Investigators and sponsors of clinical trials have an ethical obligation to disseminate clinical trial results, whether positive or negative, in a timely manner. OBJECTIVES. To determine the publication rate and average time to reporting for clinical trials carried out in South Africa (SA) and to explore factors indicating whether a study is published or not. METHODS. A registry-based quantitative retrospective analysis of 79 SA clinical trials for new medicines registered between January 2008 and December 2010 was performed. The relevant trial identification number in the register was used to track all peer-reviewed publications subsequent to registration. Tracking of clinical trials was done through a systematic literature search of the electronic journal databases of the South African Medical Journal (SAMJ), the Cochrane Library, Public Library of Science Medical Journal (PLoS Medicine) and BioMed Central, all of which are indexed on MEDLINE via PubMed. In addition, a manual search of the Open Access Journal of Clinical Trials databases and reference lists on articles related to the trial medicine was performed. RESULTS. Of the 79 clinical trials surveyed, 72 were concluded by December 2014. Only 35 (48.6%) of them had the results published in a peer-reviewed journal, the current benchmark for dissemination of trial results. The majority (82.9%) of those published had a positive outcome. Of the 35 trials that were published, 77.1% were published within 2 years. The average time from completion to initial reporting was 22 months. Fewer than half (40.5%) of the clinical trials surveyed were placebo controlled. CONCLUSION. The absence of complete outcomes data from SA clinical trials warrants utmost attention. The study puts forward a case to the regulatory body and research ethics committees to compel all data from clinical trials to be made accessible to clinicians and the public in general by being published in an easily accessible form and in a timely manner.
机译:背景。临床试验的研究者和发起者有道德责任及时发布临床试验结果,无论是肯定的还是阴性的。目标确定在南非(SA)进行的临床试验的发表率和平均报告时间,并探讨表明一项研究是否发表的因素。方法。对2008年1月至2010年12月期间注册的79种新药的SA临床试验进行了基于注册表的定量回顾性分析。登记册中的相关试验标识号用于跟踪登记后所有经过同行评审的出版物。通过对《南非医学杂志》(SAMJ),《科克伦图书馆》,《科学医学公共杂志》(PLoS Medicine)和《生物医学中心》(BioMed Central)的电子期刊数据库进行系统文献检索,对临床试验进行了跟踪。 MEDLINE通过PubMed。此外,还对《开放存取临床试验期刊》数据库和与该试验药物有关的文章的参考文献列表进行了手动搜索。结果。在接受调查的79项临床试验中,有72项在2014年12月之前完成。其中只有35项(48.6%)的结果发表在同行评审期刊上,该期刊是目前传播试验结果的基准。大部分(82.9%)的发表者有积极的结果。在已发布的35个试验中,有77.1%在两年内发布。从完成到首次报告的平均时间为22个月。少于一半(40.5%)的临床试验是安慰剂对照的。结论。缺乏来自SA临床试验的完整结果数据值得高度关注。这项研究向监管机构和研究伦理委员会提出了一个案例,要求他们以一种易于获取的形式及时发布临床试验中的所有数据,以使临床医生和一般公众可以访问。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号